Novo Nordisk AS (WBO:NNO2) Stock News, Headlines & Updates
Novo Nordisk AS Stock News from GuruFocus
- 1
- 2
- 3
Jul 17, 2025
Novo Nordisk (NVO) Invests in Quantum Computing Initiative
GuruFocus News • 6:57am
Jul 11, 2025
Novo Nordisk AS (NVO) Shares Down 3.17% on Jul 11
GuruFocus News • 12:03pm
Jul 08, 2025
Novo Nordisk (NVO) Seeks EU Approval for Higher Dose of Wegovy
GuruFocus News • 10:55am
Jun 26, 2025
Novo Nordisk (NVO) Partners with WeightWatchers for Wegovy Distribution
GuruFocus News • 11:57am
Novo Nordisk Expands Access to FDA-Approved Wegovy® Through New Collaborations | NVO stock news
GuruFocus News • 11:04am
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety
PRNewswire • 11:00am
Novo Nordisk (NVO) Expands Wegovy Access Through WeightWatchers Partnership | NVO Stock News
GuruFocus News • 10:45am
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety | NVO Stock News
GuruFocus News • 10:30am
Jun 25, 2025
NVO Stock Declines Amid Termination of Hims & Hers Partnership
GuruFocus News • 2:25pm
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Announced -- Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Business Wire • 2:00pm
Telehealth Firm Pushes Back on Novo Nordisk's Semaglutide Ruling
Undercovered Deep Insights • 12:36pm
NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm
Business Wire • 11:00am
Novo Nordisk A/S (NVO) Investors Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Business Wire • 9:00am
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Announced -- Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Business Wire • 7:00pm
Jun 24, 2025
Novo Nordisk (NVO) Receives EU Panel's Nod for Ozempic Label Update
GuruFocus News • 8:59am
Novo Nordisk's $50 Obesity Shot Hits India -- The Drug War Just Got Real
Khac Phu Nguyen • 5:42am
NVO Expands Indian Market with Wegovy Launch
GuruFocus News • 4:55am
Jun 23, 2025
NVO Stock Drops Amid Partnership Termination and Trial Results
GuruFocus News • 1:50pm
Novo Nordisk AS (NVO) Trading Down 6.52% on Jun 23
GuruFocus News • 12:05pm
Novo Nordisk (NVO) Achieves Significant Weight Loss Results in Phase 3 Trial | NVO Stock News
GuruFocus News • 11:23am
Novo Nordisk (NVO) Highlights Positive Results from Mim8 Prophylaxis Trial | NVO Stock News
GuruFocus News • 11:23am
Novo Nordisk (NVO) Ends Partnership with Hims & Hers Health Amid Safety Concerns
GuruFocus News • 9:56am
Novo Nordisk Ends Collaboration with Hims & Hers Over Safety Concerns | NVO stock news
GuruFocus News • 8:07am
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
PRNewswire • 8:00am
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing | NVO Stock News
GuruFocus News • 7:16am
Jun 21, 2025
Novo Nordisk (NVO) Reveals Promising Amycretin Trial Results
GuruFocus News • 7:55am
Jun 20, 2025
Novo Nordisk (NVO) Price Target Cut by Argus, Growth Outlook Remains Strong | NVO Stock News
GuruFocus News • 12:15pm
ACC Endorsement Boosts Novo Nordisk (NVO) Stock
GuruFocus News • 10:56am
Jun 18, 2025
Judge Upholds FDA Decision Impacting Novo Nordisk (NVO) Drug Copies
GuruFocus News • 4:55pm
Jun 16, 2025
NVO Stock Declines Amid Rival's Strategic Move
GuruFocus News • 5:25pm
Novo Nordisk (NVO) Sees Price Target Cut by JPMorgan | NVO Stock News
GuruFocus News • 12:15pm
Jun 12, 2025
NVO Stock Jumps on Positive Amycretin Trial News
GuruFocus News • 5:25pm
Novo Nordisk (NVO) Advances Obesity Drug Amycretin to Phase 3 Trials
GuruFocus News • 1:55pm
Novo Nordisk (NVO) Faces Potential Ban on U.S. Drug Ads
GuruFocus News • 1:55pm
Novo Nordisk (NVO) Advances Amycretin to Phase 3 for Weight Management | NVO Stock News
GuruFocus News • 12:45pm
Strong Option Activity Boosts Novo Nordisk (NVO) Outlook | NVO Stock News
GuruFocus News • 11:00am
Jun 11, 2025
Novo Nordisk (NVO) Partners With Deep Apple for Obesity Drug Development
GuruFocus News • 9:57am
Jun 10, 2025
NVO Stock Rises Amid Hedge Fund Activity and New Trial Data
GuruFocus News • 12:50pm
Novo Nordisk AS (NVO) Shares Up 6.37% on Jun 10
GuruFocus News • 12:08pm
Novo Nordisk (NVO) Launches New Phase 3 Trial for CagriSema
GuruFocus News • 11:58am
- 1
- 2
- 3
Show
Entries
Headlines
Total 0- 1
No recent news